Twist Bioscience Corporation (1TWST)
MTA
Closed
Oct 2, 2026
Day's Range
169.2552 wk Range
21.70Overview - 1TWST - Twist Bioscience Corporation
Key Statistics
Valuation
Enterprise Value
9.31B
P/E (Trailing)
‪-130.19‬
PEG Ratio
‪0.49‬
Price / Sales (TTM)
‪26.01‬
Price / Book
‪27.09‬
EV / EBITDA
‪-91.64‬
Profitability
Gross Margin
‪52.75%‬
Profit Margin
‪-31.66%‬
Operating Margin
‪-30.64%‬
Return on Assets
‪-13.08%‬
Return on Equity
‪-29.59%‬
Ownership
Shares Outstanding
62.67M
Float
61.96M
Held by Insiders
‪0.76%‬
Held by Institutions
‪116.91%‬
Price stats
Beta
‪2.22‬
50-Day Avg
‪112.83‬
200-Day Avg
‪65.47‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 1TWST - Twist Bioscience Corporation
Peers - 1TWST - Twist Bioscience Corporation
Peer Comparison
Compared with companies in Biotechnology listed on MTA.
Profile Summary - 1TWST - Twist Bioscience Corporation
About
Twist Bioscience Corporation is a synthetic biology company that develops and sells DNA-based products for research and commercial applications. Twist Bioscience Corporation’s portfolio includes synthetic genes, gene fragments, oligonucleotide pools, and antibody libraries used in therapeutic discovery, diagnostics,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
